Newfound Research LLC Merck & Co., Inc. Transaction History

Newfound Research LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$73.51 - $82.4 $86,227 - $96,655	-1,173 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$72.28 - $90.54 $28,622 - $35,853	-396 Reduced 25.24%	1,173 $90,000
Q3 2021 Oct 14, 2021	BUY	$71.68 - $78.83 $29,532 - $32,477	412 Added 35.61%	1,569 $118,000
Q2 2021 Jul 19, 2021	BUY	$70.31 - $77.77 $10,546 - $11,665	150 Added 14.9%	1,157 $90,000
Q1 2021 Apr 28, 2021	SELL	$68.86 - $81.11 $30,849 - $36,337	-448 Reduced 30.79%	1,007 $78,000
Q4 2020 Jan 22, 2021	BUY	$71.77 - $79.65 $81,961 - $90,960	1,142 Added 364.86%	1,455 $119,000
Q3 2020 Oct 20, 2020	BUY	$73.18 - $82.95 $22,905 - $25,963	313 New	313 $26,000

3,827

1.87B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Newfound Research LLC, based on Form 13F filings with the SEC.

Stay updated on Newfound Research LLC with notifications on news.